Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
JKU Lab, |
RCV004586481 | SCV005073979 | likely pathogenic | Hypophosphatasia | 2024-06-11 | criteria provided, single submitter | clinical testing | The variant is absent from GnomAD. The ACMG criteria applied can be looked up in the ALPL gene variant database. https://alplmutationdatabase.jku.at |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004690511 | SCV005185026 | uncertain significance | not specified | 2024-05-23 | criteria provided, single submitter | clinical testing | Variant summary: ALPL c.1327G>T (p.Ala443Ser) results in a conservative amino acid change located in the Alk_phosphatase domain (IPR001952) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 245870 control chromosomes. c.1327G>T has been reported in the literature in the presumed compound heterozygous state in at least 1 individual affected with autosomal recessive Hypophosphatasia (example, Pierpont_2021). These data do not allow any conclusion about variant significance. A different variant affecting the same codon has been classified as pathogenic by our lab (c.1328C>T, p.Ala443Val), supporting the critical relevance of codon 443 to ALPL protein function. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 33579333). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
Fulgent Genetics, |
RCV005015203 | SCV005644701 | likely pathogenic | Adult hypophosphatasia; Childhood hypophosphatasia; Infantile hypophosphatasia | 2024-05-24 | criteria provided, single submitter | clinical testing |